MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Proceeds from issuanceconvertible note payable,...$5,580,000 Net cash provided byfinancing activities$5,433,568 Canceled cashflow$146,432 Net change in cash$19,832 Canceled cashflow$5,413,736 Payment on notespayable-Related Party$146,432 Stock-based compensation$2,418,516 Amortization of prepaidcontracts$766,666 Increase in accountspayable and accrued...$242,163 Non-cash financing cost$200,000 Increase in accruedinterest$38,765 Interest expense paidthrough sale of common...$22,521 Increase in other currentassets-$7,544 Increase in deferredrevenue$735 Net change in cash$19,832 Net cash used inoperating activities-$5,413,736 Canceled cashflow$3,696,910 Net loss-$8,644,897 Gain on change in fairvalue of convertible...$281,932 Increase in inventory$159,790 Decrease in accruedcompensation-$17,736 Decrease in operatinglease right of use...$3,654 Increase in accountsreceivable$2,637
Cash Flow
source: myfinsight.com

JUPITER NEUROSCIENCES, INC. (JUNS)

JUPITER NEUROSCIENCES, INC. (JUNS)